Get Used to Living Longer

We’re family-owned and operated with a 70-year history of bringing life-prolonging therapies to patients who need them most.

People Are Our Mission

It starts with close relationships with our patients, physicians, and a global commitment to provide premium healthcare for all.

Discover Our Difference

Uncommon Pursuit

We’re addressing unmet needs through novel preparations and orphan drugs, and relentlessly building a pipeline of treatments in cardiology, ophthalmology, and urology.

Find Out More

AGEPHA Pharma in the News

U.S. FDA Approves First Anti-Inflammatory Drug for Cardiovascular Disease

LODOCO® (colchicine, 0.5 mg tablets) reduces cardiac event risk in adult patients with established Atherosclerotic Cardiovascular Disease (ASCVD) by an additional 31% on top of standard of care including high intensity statins.